Metabolic engineering of Glarea lozoyensis for high-level production of pneumocandin B0
Pneumocandin B0 (PB0) is a lipohexapeptide synthesized by Glarea lozoyensis and serves as the precursor for the widely used antifungal drug caspofungin acetate (Cancidas®). However, the low titer of PB0 results in fermentation and purification costs during caspofungin production, limiting its widesp...
Saved in:
| Main Authors: | Xinyi Zhang, Shu Cheng, Jing Yang, Li Lu, Zixin Deng, Guangkai Bian, Tiangang Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2025-06-01
|
| Series: | Synthetic and Systems Biotechnology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405805X24001601 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In vitro susceptibility profiles of 16 antifungal drugs against Trichophyton indotineae
by: Wenting Xie, et al.
Published: (2025-08-01) -
COVID-19 pandemic and the evolving epidemiology of Candidemia: A topic of concern!!!
by: Ekadashi Rajni, et al.
Published: (2022-09-01) -
Improved Sixty-Day Mortality in Candidemia with Antifungal Treatment Within 72 Hours of Fever Onset: A Single-Center Retrospective Study in Rural Japan
by: Koji Hayashi, et al.
Published: (2025-04-01) -
Breakthrough invasive candidiasis in pediatric patient with Ewing’s sarcoma: dinical case report and literature review
by: Yu. V. Dinikina, et al.
Published: (2019-12-01) -
A benchmark dataset for validating FKS1 mutations in Candida auris
by: Elizabeth Misas, et al.
Published: (2025-08-01)